BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 24837409)

  • 1. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
    Ma D
    Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphiphilic gold nanoparticles displaying flexible bifurcated ligands as a carrier for siRNA delivery into the cell cytosol.
    Niikura K; Kobayashi K; Takeuchi C; Fujitani N; Takahara S; Ninomiya T; Hagiwara K; Mitomo H; Ito Y; Osada Y; Ijiro K
    ACS Appl Mater Interfaces; 2014 Dec; 6(24):22146-54. PubMed ID: 25466488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smart multilayered assembly for biocompatible siRNA delivery featuring dissolvable silica, endosome-disrupting polycation, and detachable PEG.
    Suma T; Miyata K; Anraku Y; Watanabe S; Christie RJ; Takemoto H; Shioyama M; Gouda N; Ishii T; Nishiyama N; Kataoka K
    ACS Nano; 2012 Aug; 6(8):6693-705. PubMed ID: 22835034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short interfering RNA therapeutics: nanocarriers, prospects and limitations.
    Mehrotra N; Tripathi RM
    IET Nanobiotechnol; 2015 Dec; 9(6):386-95. PubMed ID: 26647816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
    Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
    Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
    Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
    Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA.
    Zhu J; Qiao M; Wang Q; Ye Y; Ba S; Ma J; Hu H; Zhao X; Chen D
    Biomaterials; 2018 Apr; 162():47-59. PubMed ID: 29432988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
    Endoh T; Ohtsuki T
    Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity.
    Pittella F; Zhang M; Lee Y; Kim HJ; Tockary T; Osada K; Ishii T; Miyata K; Nishiyama N; Kataoka K
    Biomaterials; 2011 Apr; 32(11):3106-14. PubMed ID: 21272932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in copolymer-mediated siRNA delivery.
    Wu ZW; Chien CT; Liu CY; Yan JY; Lin SY
    J Drug Target; 2012 Aug; 20(7):551-60. PubMed ID: 22758393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endosomal escape kinetics of mesoporous silica-based system for efficient siRNA delivery.
    Wang M; Li X; Ma Y; Gu H
    Int J Pharm; 2013 May; 448(1):51-7. PubMed ID: 23524121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
    Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
    Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model.
    Lin Q; Jin CS; Huang H; Ding L; Zhang Z; Chen J; Zheng G
    Small; 2014 Aug; 10(15):3072-82. PubMed ID: 24706435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. siRNA transfection with calcium phosphate nanoparticles stabilized with PEGylated chelators.
    Giger EV; Castagner B; Räikkönen J; Mönkkönen J; Leroux JC
    Adv Healthc Mater; 2013 Jan; 2(1):134-44. PubMed ID: 23184402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.
    Resnier P; LeQuinio P; Lautram N; André E; Gaillard C; Bastiat G; Benoit JP; Passirani C
    Biotechnol J; 2014 Nov; 9(11):1389-401. PubMed ID: 25262914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock.
    Lee SH; Choi SH; Kim SH; Park TG
    J Control Release; 2008 Jan; 125(1):25-32. PubMed ID: 17976853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
    Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
    ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity.
    Konca YU; Kirshenbaum K; Zuckermann RN
    Int J Nanomedicine; 2014; 9():2271-85. PubMed ID: 24872690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.